Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Transcytosis of IgG01:15

Transcytosis of IgG

3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Physiological Barriers01:25

Physiological Barriers

5.0K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

99
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

68
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving Approaches to Congenital Diaphragmatic Hernia Management.

NeoReviews·2026
Same author

Combinatorial base editing couples disease correction with lineage amplification in hematopoietic stem and progenitor cells.

bioRxiv : the preprint server for biology·2026
Same author

In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.

Blood advances·2026
Same author

Single-cell spatiotemporal dissection of the human maternal-fetal interface.

Nature·2026
Same author

Investigating trophoblast invasion and angiogenesis expression changes in a caloric deficient mouse model of fetal growth restriction.

Reproductive biology·2026
Same author

Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Apr 30, 2026

Isolation of Leukocytes from the Human Maternal-fetal Interface
08:19

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on: May 21, 2015

15.7K

Maternal-fetal cellular trafficking: clinical implications and consequences.

Cerine Jeanty1, S Christopher Derderian, Tippi C Mackenzie

  • 1Eli and Edythe Broad Center of Regeneration Medicine and the Department of Surgery, University of California San Francisco, San Francisco, California, USA.

Current Opinion in Pediatrics
|April 25, 2014
PubMed
Summary

Maternal-fetal cellular trafficking (MFCT) involves cell exchange between mother and fetus. This process has implications for pregnancy, immune tolerance, and diseases like cancer and autoimmune conditions.

More Related Videos

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.0K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

Isolation of Leukocytes from the Human Maternal-fetal Interface
08:19

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on: May 21, 2015

15.7K
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.0K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K

Area of Science:

  • Reproductive biology
  • Immunology
  • Genetics

Background:

  • Maternal-fetal cellular trafficking (MFCT) describes the bidirectional exchange of cells between mother and fetus.
  • This phenomenon leads to fetal microchimerism (fetal cells in mother) and maternal microchimerism (maternal cells in fetus).
  • The precise biological role of MFCT remains under investigation, but it's linked to fetal immune development, pregnancy tolerance, and tissue repair.

Purpose of the Study:

  • To review the clinical implications of MFCT.
  • To explore MFCT's role in pregnancy, fetal surgery, autoimmune diseases, transplantation, and cancer.

Main Methods:

  • This review synthesizes current research on MFCT.
  • It examines existing literature on the clinical applications and biological significance of microchimerism.

Main Results:

  • MFCT has demonstrated clinical utility in prenatal testing for aneuploidies and predicting pregnancy complications.
  • Transplacental cell passage influences immune priming and tolerance, impacting autoimmune disease and transplantation outcomes.
  • Ongoing research is exploring microchimerism's predictive value for graft rejection risk.

Conclusions:

  • MFCT plays a significant role in pregnancy and beyond.
  • Understanding MFCT is crucial for advancements in prenatal diagnostics, autoimmune disease management, and transplantation success.
  • Further research into MFCT's mechanisms and applications is warranted.